Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Eriksson

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Lab on a Chip|February 18, 2010
A microfluidic device for reversible environmental changes around single cells using optical tweezers for cell selection and positioningEmma Eriksson, Kristin Sott, Fredrik Lundqvist, et al.
Journal of Cellular and Molecular Medicine|March 18, 2024
CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signallingSedigheh Naseri, Mariela Mejia Cordova, Jessica Wenthe, et al.
Journal of Translational Medicine|July 27, 2023
Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma modelsJessica Wenthe, Emma Eriksson, Ann-Charlotte Hellström, et al.
Journal of Leukocyte Biology|March 16, 2007
Role of IRAK4 and IRF3 in the control of intracellular infection with Chlamydia pneumoniaeChristian Trumstedt, Emma Eriksson, Anna M Lundberg, et al.
Lab on a Chip|December 21, 2006
A microfluidic system in combination with optical tweezers for analyzing rapid and reversible cytological alterations in single cells upon environmental changesEmma Eriksson, Jonas Enger, Bodil Nordlander, et al.
Vaccines|February 28, 2023
A Comparison of Strategies to Improve Uptake of COVID-19 Vaccine among High-Risk Adults in Nairobi, Kenya in 2022Joan Yego, Robert Korom, Emma Eriksson, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2021
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapyJessica Wenthe, Sedigheh Naseri, Alireza Labani-Motlagh, et al.
Infection and Immunity|May 25, 2004
Role of flagellin and the two-component CheA/CheY system of Listeria monocytogenes in host cell invasion and virulenceLone Dons, Emma Eriksson, Yuxuan Jin, et al.
Molecular Therapy Oncolytics|February 10, 2022
Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibitionJessica Wenthe, Sedigheh Naseri, Ann-Charlotte Hellström, et al.
Cancer Research|October 19, 2007
Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in miceFarasat Zaman, Victoria Menendez-Benito, Emma Eriksson, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Lab on a Chip|February 18, 2010
A microfluidic device for reversible environmental changes around single cells using optical tweezers for cell selection and positioningEmma Eriksson, Kristin Sott, Fredrik Lundqvist, et al.
Journal of Cellular and Molecular Medicine|March 18, 2024
CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signallingSedigheh Naseri, Mariela Mejia Cordova, Jessica Wenthe, et al.
Journal of Translational Medicine|July 27, 2023
Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma modelsJessica Wenthe, Emma Eriksson, Ann-Charlotte Hellström, et al.
Journal of Leukocyte Biology|March 16, 2007
Role of IRAK4 and IRF3 in the control of intracellular infection with Chlamydia pneumoniaeChristian Trumstedt, Emma Eriksson, Anna M Lundberg, et al.
Lab on a Chip|December 21, 2006
A microfluidic system in combination with optical tweezers for analyzing rapid and reversible cytological alterations in single cells upon environmental changesEmma Eriksson, Jonas Enger, Bodil Nordlander, et al.
Vaccines|February 28, 2023
A Comparison of Strategies to Improve Uptake of COVID-19 Vaccine among High-Risk Adults in Nairobi, Kenya in 2022Joan Yego, Robert Korom, Emma Eriksson, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2021
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapyJessica Wenthe, Sedigheh Naseri, Alireza Labani-Motlagh, et al.
Infection and Immunity|May 25, 2004
Role of flagellin and the two-component CheA/CheY system of Listeria monocytogenes in host cell invasion and virulenceLone Dons, Emma Eriksson, Yuxuan Jin, et al.
Molecular Therapy Oncolytics|February 10, 2022
Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibitionJessica Wenthe, Sedigheh Naseri, Ann-Charlotte Hellström, et al.
Cancer Research|October 19, 2007
Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in miceFarasat Zaman, Victoria Menendez-Benito, Emma Eriksson, et al.
Pageof 5